Migraine Drugs Market Size, Share & Trends Report

Migraine Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Triptans, CGRP-based Therapies, Ditans, Neurotoxins, NSAIDs), By Treatment, By Route Of Administration, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-2-68038-559-5
  • Number of Pages: 98
  • Format: Electronic (PDF)

Market Segmentation

  • Migraine Drugs Treatment Outlook (Revenue, USD Million, 2017 - 2025)
    • Acute Treatment
    • Preventive Treatment
  • Migraine Drugs Therapeutic Class Outlook (Revenue, USD Million, 2017 - 2025)
    • Triptans
    • Acetylcholine Inhibitors/ neurotoxins
    • Ergot Alkaloids
    • NSAIDs
    • Ditans
    • CGRP Small molecule antagonists
    • CGRP monoclonal antibodies
    • Others
  • Migraine Drugs Route of Administration Outlook (Revenue, USD Million, 2017 - 2025)
    • Oral
    • Injectables
    • Others
  • Migraine Drugs Country Outlook (Revenue, USD Million, 2017 - 2025)
    • The U.S.
      • The U.S. Migraine Drugs Market, by Treatment
        • Acute Treatment
        • Preventive Treatment
      • The U.S. Migraine Drugs Market, by Therapeutic Class
        • Triptans
        • Acetylcholine Inhibitors/ neurotoxins
        • Ergot Alkaloids
        • NSAIDs
        • Ditans
        • CGRP Small molecule antagonists
        • CGRP monoclonal antibodies
        • Others
      • The U.S. Migraine Drugs Market, by Route of Administration
        • Oral
        • Injectables
        • Others
    • The U.K.
      • The U.K. Migraine Drugs Market, by Treatment
        • Acute Treatment
        • Preventive Treatment
      • The U.K. Migraine Drugs Market, by Therapeutic Class
        • Triptans
        • Acetylcholine Inhibitors/ neurotoxins
        • Ergot Alkaloids
        • NSAIDs
        • Ditans
        • CGRP Small molecule antagonists
        • CGRP monoclonal antibodies
        • Others
      • The U.K. Migraine Drugs Market, by Route of Administration
        • Oral
        • Injectables
        • Others
    • Japan
      • Japan Migraine Drugs Market, by Treatment
        • Acute Treatment
        • Preventive Treatment
      • Japan Migraine Drugs Market, by Therapeutic Class
        • Triptans
        • Acetylcholine Inhibitors/ neurotoxins
        • Ergot Alkaloids
        • NSAIDs
        • Ditans
        • CGRP Small molecule antagonists
        • CGRP monoclonal antibodies
        • Others
      • Japan Migraine Drugs Market, by Route of Administration
        • Oral
        • Injectables
        • Others
    • Germany
      • Germany Migraine Drugs Market, by Treatment
        • Acute Treatment
        • Preventive Treatment
      • Germany Migraine Drugs Market, by Therapeutic Class
        • Triptans
        • Acetylcholine Inhibitors/ neurotoxins
        • Ergot Alkaloids
        • NSAIDs
        • Ditans
        • CGRP Small molecule antagonists
        • CGRP monoclonal antibodies
        • Others
      • Germany Migraine Drugs Market, by Route of Administration
        • Oral
        • Injectables
        • Others
    • France
      • France Migraine Drugs Market, by Treatment
        • Acute Treatment
        • Preventive Treatment
      • France Migraine Drugs Market, by Therapeutic Class
        • Triptans
        • Acetylcholine Inhibitors/ neurotoxins
        • Ergot Alkaloids
        • NSAIDs
        • Ditans
        • CGRP Small molecule antagonists
        • CGRP monoclonal antibodies
        • Others
      • France Migraine Drugs Market, by Route of Administration
        • Oral
        • Injectables
        • Others
    • Italy
      • Italy Migraine Drugs Market, by Treatment
        • Acute Treatment
        • Preventive Treatment
      • Italy Migraine Drugs Market, by Therapeutic Class
        • Triptans
        • Acetylcholine Inhibitors/ neurotoxins
        • Ergot Alkaloids
        • NSAIDs
        • Ditans
        • CGRP Small molecule antagonists
        • CGRP monoclonal antibodies
        • Others
      • Italy Migraine Drugs Market, by Route of Administration
        • Oral
        • Injectables
        • Others
    • Spain
      • Spain Migraine Drugs Market, by Treatment
        • Acute Treatment
        • Preventive Treatment
      • Spain Migraine Drugs Market, by Therapeutic Class
        • Triptans
        • Acetylcholine Inhibitors/ neurotoxins
        • Ergot Alkaloids
        • NSAIDs
        • Ditans
        • CGRP Small molecule antagonists
        • CGRP monoclonal antibodies
        • Others
      • Spain Migraine Drugs Market, by Route of Administration
        • Oral
        • Injectables
        • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2017 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon